Six-planet ‘parade' puts Venus, Jupiter and Mercury in rare morning lineup
The phenomenon happens when multiple planets seem to align from Earth's perspective, creating a line across the night or early morning sky.
These events typically occur at least once a year, but the number of visible planets changes each time.
In January, six planets were visible, and in February, all eight planets of the solar system appeared — though some required binoculars or a telescope to see.
This month, Venus, Jupiter, Saturn and Mercury can be spotted without any equipment, with the best viewing opportunities over the next week.
Uranus and Neptune will also be in the lineup, but they can only be seen with binoculars or a telescope.
Earlier this week, Jupiter and Venus passed very close to each other and are still positioned near one another in the eastern sky — 'close together like cat's eyes,' said Carolyn Sumners of the Houston Museum of Natural Science.
The best viewing time is shortly before sunrise, looking toward the east.
Jupiter and Venus will appear near each other, Saturn will be farther to the side, and Mercury will be low near the horizon.
Mercury will reach its farthest point from the sun on Tuesday morning, making it easier to spot before it disappears into the sun's glare later in the month.
'You're looking for little tiny pinpoints of light, but they are the brightest ones,' said Justin Bartel with the Science Museum of Virginia. 'They don't really twinkle like the stars do.'
NASA recommends finding a spot with a clear, cloudless sky and an unobstructed view, away from tall buildings or other structures.
Toward the end of the month, Mercury will move behind the sun, but a crescent moon will join the lineup.
The next major planetary grouping will happen in February.
Solve the daily Crossword
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
an hour ago
- Fox News
Cancer vaccine shows promise in preventing recurrence of pancreatic, colorectal tumors
An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, researchers tested the vaccine (ELI-002 2P) with 25 patients who had been treated for pancreatic and colorectal cancer. The patients had all undergone surgery to remove tumors and showed "signs of minimal residual disease" or traces of DNA, putting them at a high risk of recurrence, according to a UCLA press release. More than 80% of pancreatic cancer patients experience recurrence of the disease after surgery, research shows — and for 40% to 50%, this happens within the first year. For colorectal cancer, the recurrence rate is between 30% and 50% and is most likely to occur within the first two years after surgery. Mutations in the KRAS gene are responsible for half of colorectal cancers and more than 90% of pancreatic cancers. The vaccine, which targets those mutations, was given via a series of injections to activate an immune response in the lymph nodes. A majority (21 out of 25) of the patients generated "KRAS-specific T cells," which indicates a stronger immune response. The ones with higher T-cell responses showed a longer relapse-free survival compared to those with lower responses, the researchers found. For three colorectal cancer patients and three pancreatic cancer patients, the vaccine appeared to remove all disease biomarkers. Among the patients who showed the strongest immune response, a majority were still cancer-free nearly 20 months after receiving the vaccine. The findings were published in Nature Medicine. "This is an exciting advance for patients with KRAS-driven cancers, particularly pancreatic cancer, where recurrence after standard treatment is almost a given and effective therapies are limited," said first author of the study, Zev Wainberg, M.D., professor of medicine at the David Geffen School of Medicine at UCLA and researcher in the UCLA Health Jonsson Comprehensive Cancer Center, in the release. "We observed that patients who developed strong immune responses to the vaccine remained disease-free and survived for much longer than expected." "The new cancer vaccine from UCLA is very promising as a major tool against these cancers." In another finding, 67% of the patients in the trial showed immune responses to "additional tumor-associated mutations," indicating that the vaccine could be used to suppress "broader anti-tumor activity." One of the benefits of ELI-002 2P, according to the researchers, is that it's considered "off-the-shelf," which means it's a mass-produced, standardized vaccine that doesn't have to be personalized for each individual patient. "This study shows that the ELI-002 2P vaccine can safely and effectively train the immune system to recognize and fight cancer-driving mutations," Wainberg said. "It offers a promising approach to generating precise and durable immune responses without the complexity or cost of fully personalized vaccines." The team has already finished enrolling participants for a phase 2 study that will test ELI-002 7P, the next iteration of the vaccine that will target a "broader set" of KRAS mutations, the release stated. The study was sponsored and funded by Elicio Therapeutics, the Massachusetts company that developed the vaccine. It was conducted in conjunction with the MD Anderson Cancer Center and the Memorial Sloan Kettering Cancer Center. Dr. Marc Siegel, Fox News senior medical analyst, was not involved in the study but commented that targeted therapies are becoming increasingly important tools in the fight against cancer. "Solid tumors, especially pancreatic, can be difficult to treat because they are not as mutagenic (capable of inducing or causing mutations) as hematological malignancies (blood cancers) or melanoma, for example, so they don't have as many ready targets for immunotherapy," he told Fox News Digital. For more Health articles, visit "The new cancer vaccine from UCLA is very promising as a major tool against these cancers, as it 'programs' the immune system to target these mutations and has been shown in the NATURE study to elicit a strong clinical response."
Gizmodo
an hour ago
- Gizmodo
‘Stranger Things' Creators are Jumping Ship to Paramount
By the time Stranger Things wraps at year's end, creators Matt and Ross Duffer will have taken their talents over to Paramount. Days ago, reports began to surface alleging the two brothers were potentially looking to leave the streamer to make film and TV for the Mission: Impossible studio. Now, it's official: per industry journalist Matt Belloni, the Duffers will be over at Paramount going forward. Their decision apparently came down to the theaters; the brothers wanted their films to hit the big screen, which Netflix isn't really keen on doing unless said film could be a potential Oscar winner, high-profile directors really fight for it, or it gets so popular that they may as well come to theaters. To date, the brothers have only released one film, the 2015 psychological thriller Hidden. With the Duffers gone, this marks Netflix's first big talent shakeup in the wake of the recent, equally big acquisition of Paramount by longtime partner Skydance. According to Variety, the duo's future output will emphasize tentpole movies, which is typically the studio's bread and butter. Despite the move, they'll still have a presence at Netflix for a while: their production company, Upside Down Productions, is working on an animated Stranger Things prequel Tales of 85 due 2026 and a second unannounced spinoff. There's also the non-Stranger series The Boroughs and Something Very Bad is Going to Happen, which they're executive producing and will also arrive in 2026. As for the core Stranger Things show, it releases in three parts on November 26, Christmas Day, and New Year's Eve. Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what's next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who.
Yahoo
an hour ago
- Yahoo
Homeowner's camera captures rare footage of unexpected visitors playing in creek: 'For me, it was very exciting'
Homeowner's camera captures rare footage of unexpected visitors playing in creek: 'For me, it was very exciting' Habitat loss and trapping slashed the common river otter's population in the late 1800s, according to the Ohio Department of Natural Resources. The mammal was hunted to extremes during the Fur Trade Era (1600 to 1850) but was reintroduced in Ohio from 1986 to 1993. Because of this reintroduction, the presence of river otters has been confirmed in 86 of 88 Ohio counties as of 2020. As these animals thrive, biodiversity is reinstated in areas where the river otter once ruled. Oxford, Ohio, resident Jim Hermann captured images on his trail cameras of river otters playing on his property, per The Miami Student. Hermann told the newspaper: "For me, it was very exciting. … I wouldn't have expected them here." While Hermann set up his trail cameras to watch the beavers that were chewing on his trees, he was treated to a rare sight. Trail cameras are good for this. Researchers use them to watch animals in their natural habitats and track the populations of endangered species. For instance, Galápagos Conservancy uses trail cameras to classify native animals and track their behaviors and population changes. It then uses this data to determine what a species may need to be better served by conservationists. Of course, these devices are not just used by conservation organizations. Anyone can set them up to spy on animals at play with the added possibility of surprise appearances of rare critters. When these sightings are reported, as they are encouraged to be, officials can add data to their studies on animal population changes and track the results of rehabilitation efforts. Organizations such as Otter Watch and the River Otter Ecology Project ask people to report sightings of otters in nature. Hermann's sighting in a town not used to seeing river otters gives hope to biologists, conservationists, and animal lovers alike. Do you think America is in a housing crisis? Definitely Not sure No way Only in some cities Click your choice to see results and speak your mind. "We want to have a healthy population that can sustain itself and provide resources," Miami University student Aiden Schmeling said to The Miami Student. "They are a mid-upper level predator on fish and aquatic life, so that indicates there's adequate water quality for our fish. It tells us that we have a big enough ecosystem to support a predator." Hermann told the newspaper: "There are bright spots. One of those bright spots is the reappearance of these big mammal and bird species that have come back to Ohio." Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword
